Osslund T D, Syed R, Singer E, Hsu E W, Nybo R, Chen B L, Harvey T, Arakawa T, Narhi L O, Chirino A, Morris C F
Amgen, Amgen Center, Thousand Oaks, California 91320-1789, USA.
Protein Sci. 1998 Aug;7(8):1681-90. doi: 10.1002/pro.5560070803.
A comprehensive deletion, mutational, and structural analysis of the native recombinant keratinocyte growth factor (KGF) polypeptide has resulted in the identification of the amino acids responsible for its biological activity. One of these KGF mutants (delta23KGF-R144Q) has biological activity comparable to the native protein, and its crystal structure was determined by the multiple isomorphous replacement plus anomalous scattering method (MIRAS). The structure of KGF reveals that it folds into a beta-trefoil motif similar to other members of fibroblast growth factor (FGF) family whose structures have been resolved. This fold consists of 12 anti-parallel beta-strands in which three pairs of the strands form a six-stranded beta-barrel structure and the other three pairs of beta-strands cap the barrel with hairpin triplets forming a triangular array. KGF has 10 well-defined beta strands, which form five double-stranded anti-parallel beta-sheets. A sixth poorly defined beta-strand pair is in the loop between residues 133 and 144, and is defined by only a single hydrogen bond between the two strands. The KGF mutant has 10 additional ordered amino terminus residues (24-33) compared to the other FGF structures, which are important for biological activity. Based on mutagenesis, thermal stability, and structural data we postulate that residues TRP125, THR126, and His127 predominantly confer receptor binding specificity to KGF. Additionally, residues GLN152, GLN138, and THR42 are implicated in heparin binding. The increased thermal stability of delta23KGF-R144Q can structurally be explained by the additional formation of hydrogen bonds between the GLN side chain and a main-chain carbonyl on an adjoining loop. The correlation of the structure and biochemistry of KGF provides a framework for a rational design of this potentially important human therapeutic.
对天然重组角质形成细胞生长因子(KGF)多肽进行全面的缺失、突变和结构分析,已确定了其具有生物活性的氨基酸。这些KGF突变体之一(delta23KGF-R144Q)具有与天然蛋白相当的生物活性,其晶体结构通过多同晶置换加反常散射法(MIRAS)确定。KGF的结构表明,它折叠成一个β-三叶基序,类似于成纤维细胞生长因子(FGF)家族中结构已解析的其他成员。这种折叠由12条反平行β-链组成,其中三对链形成一个六链β-桶结构,另外三对β-链用发夹三联体覆盖桶,形成一个三角形阵列。KGF有10条明确的β-链,形成5个双链反平行β-片层。第六对定义不明确的β-链对位于133和144位残基之间的环中,仅由两条链之间的单个氢键定义。与其他FGF结构相比,KGF突变体有10个额外的有序氨基末端残基(24-33),这对生物活性很重要。基于诱变、热稳定性和结构数据,我们推测TRP125、THR126和His127残基主要赋予KGF受体结合特异性。此外,GLN152、GLN138和THR42残基与肝素结合有关。delta23KGF-R144Q热稳定性的提高在结构上可以通过GLN侧链与相邻环上的主链羰基之间额外形成氢键来解释。KGF的结构与生物化学的相关性为合理设计这种潜在重要的人类治疗药物提供了框架。